Free Trial

Immunovant (IMVT) SEC Filings & 10K Form

Immunovant logo
$25.19 +0.42 (+1.70%)
(As of 01/2/2025 05:45 PM ET)

Recent Immunovant SEC Filings

DateFilerForm TypeView
12/18/2024
4:01 PM
Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2024
4:02 PM
Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:11 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:12 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:09 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:08 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
4:11 PM
Gloria Melanie (Reporting)
Immunovant (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2024
4:15 PM
Gloria Melanie (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
5:42 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
5:49 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
3:21 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:23 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:25 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:27 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:28 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:30 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:31 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
6:40 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
3:15 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:12 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:19 PM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
3:17 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:19 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:20 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:36 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:38 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:39 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:41 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:42 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
4:04 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
4:06 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
4:07 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
5:56 AM
Immunovant (Filer)
Form DEF 14A
06/26/2024
6:01 AM
Immunovant (Filer)
Form DEFA14A
05/29/2024
3:36 PM
Immunovant (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/26/2024
4:22 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
4:18 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
4:20 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:57 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:59 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
5:01 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
3 CENT Crypto to Explode December 16th? (Ad)

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…

04/19/2024
5:05 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
5:06 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:18 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:14 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:16 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:54 PM
Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:31 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:34 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:37 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:39 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:44 PM
Immunovant (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:46 PM
Immunovant (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:48 PM
Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:50 PM
Hughes Douglas J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:23 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:27 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:29 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:14 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:16 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:18 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:21 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:47 AM
Deep Track Capital, LP (Filed by)
Immunovant (Subject)
Form SC 13G/A
02/12/2024
6:02 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:05 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/09/2024
8:16 AM
Immunovant (Subject)
Form SC 13G
01/19/2024
3:04 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
6:29 AM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/12/2024
3:34 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:18 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:20 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:08 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMVT) was last updated on 1/3/2025 by MarketBeat.com Staff
From Our Partners